Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study
<h3>Background</h3><p dir="ltr">Enoxaparin is commonly used for venous thromboembolism (VTE) prophylaxis in adult hospitalized patients. Although anti-Xa levels are inversely related to body weight, limited studies evaluated clinical outcomes of dose reduction in the unde...
Saved in:
| Main Author: | Salam Ibrahim Abou Safrah (21264303) (author) |
|---|---|
| Other Authors: | Mohamed Omar Saad (12535545) (author), May Alasmar (19744495) (author), Fatima Ashfaq Butt (21264306) (author), Somaya Khaled Koraysh (21264309) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A systematic review and meta-analysis on the impact of early vs. delayed pharmacological thromboprophylaxis in patients with traumatic brain injury
by: Muhammad Hamza Shuja (19748620)
Published: (2024) -
Anti-xa guided enoxaparin thromboprophylaxis is associated with less thromboembolism than fixed dose dalteparin in trauma patients admitted to intensive care
by: Ahmad Kloub (16855149)
Published: (2025) -
Venous thromboembolic events after bariatric surgery: Protocol for a systematic review and meta-analysis
by: Walid El Ansari (93732)
Published: (2020) -
Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
by: Hussam Alhasson (12289540)
Published: (2021) -
D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review
by: Islam Eljilany (14151588)
Published: (2020)